期刊文献+

miR-221表达与K562/A02细胞耐药关系的探讨

The study on the relationship between the expression level of miR-221 and K562/A02 drug resistance
下载PDF
导出
摘要 目的观察miR-221表达与K562/A02细胞耐药的关系。方法常规培养K562/A02细胞株作为对照组,选择通过反义寡核苷酸特异性抑制K562/A02细胞中miR-221表达细胞株作为实验组,应用实时荧光定量RT-PCR方法检测两组细胞中miR-221表达情况。采用MTT法比较两组细胞对化疗药物的敏感性。结果荧光定量RT-PCR结果显示,实验组细胞中miR-221表达较对照组明显降低,(P<0.05),两组比较差异倍数均值为-8.43±2.18。阿霉素对实验组细胞的IC50为0.0375mg·L-1,阿霉素对对照组细胞的IC50为4.32mg·L-1,后者的耐药倍数是实验组的115倍。结论反义寡核苷酸能够抑制K562/A02细胞中miR-221的表达,这种抑制作用能够逆转K562/A02细胞对阿霉素的耐药性。miR-221表达与K562/A02细胞耐药性密切相关。 Objective To explore the relationship between the expression level of miR-221 and drug resistance of K562/A02. Method K562/A02 was cultured as control group. The experiment group K562/A02 was treated by antisense oligonucleotide to inhibit the expression of miR-221. The realtime- PCR was used to detect the miR-221 expression level and MTT was used to detect the drug sensitivity of K562/A02 of both groups. Results The expression level of miR-221 of experiment group was significant lower than that of control group (P 0.05). The mean different times of the two groups was -8.43±2.18. The IC50 of experiment and control group to adriamycin were 0.0375 mg·L-1 and 4.32 mg·L-1 respectively. The drug resistance times was 115 fold. Conclusion The expression of miR-221 in K562/A02 can be inhibited by antisense oligonucleotide, which may results in the reversal of drug resistance. The expression level of miR-221 is correlative to the drug resistance of K562/A02.
作者 曹翊雄
出处 《肿瘤药学》 CAS 2011年第2期107-109,共3页 Anti-Tumor Pharmacy
关键词 MIR-221 K562/A02细胞 耐药 阿霉素 miR-221 K562/A02 cell drug resistance adriamycin
  • 相关文献

参考文献8

  • 1崔秀英,郭运杰,姚和瑞.耐药乳腺癌细胞株MCF-7/ADR中microRNA的分析[J].南方医科大学学报,2008,28(10):1813-1815. 被引量:25
  • 2Renneville A,Roumier C,Biqqio Vet al.Cooperating gene mutations in acute myeloid leukemia:a review of the literature[].Leukemia.2008
  • 3Lee RC,Feinbaum RL,Ambros V.The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14[].Cell.1993
  • 4Reinhart BJ,Slack FJ,Basson M,et al.The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans[].Nature.2000
  • 5Escherich G,Horstmann MA,Zimmermann M,et al.Coopetative studygroup for childhood acute lymphoblastic leukemia(COALL):Long-term results of trials 82,85,89,92 and 97[].Leukemia.2010
  • 6Luqmani YA.Mechanisms of drug resistance in cancer chemo-therapy[].Med Princ Prat.2005
  • 7Tanzer A,,Stadler P F.Molecular evolution of a microRNA cluster[].Journal of Molecular Biology.2004
  • 8Sorrentino A,Liu CG,Addario A,et al.Role of miRNAsin drug-resistant ovarian cancer cells[].Gynecologic Oncology.2008

二级参考文献15

  • 1Grishok A, Pasquinelli AE, Conte D, et al. Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing [J]. Cell, 2001, 106(1): 23-34.
  • 2Ambros V. MicroRNA pathways in flies and worms: growth, death, fat,stress ,and timing[J]. Cell, 2003, 113(6): 673-6.
  • 3Carrington JC, Ambros V. Role of microRNAs in plant and animal development[J]. Science, 2003, 301(5631): 336-8.
  • 4Calin GA, Dumitru CD, Shimizu M, et al.Frequent deletions and down-regulation ofmicro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia [J]. Proc Natl Acad Sci USA, 2002, 99(24): 15524-9.
  • 5Cimmino A, Calin GA, Fabbri M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2 [J]. Proc Natl Acad Sci USA, 2005, 102(39): 13944-9.
  • 6Yanaihara N, Caplen N, Bowman E, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis [J].Cancer Cell, 2006, 9(3): 189-98.
  • 7Kovalchuk O, Tryndyak YP, Montgomery B, et al. Estrogen-induced rat breast carcinogenesis is characterized by alterations in DNA methylation, histone modifications and aberrant microRNA expression[J]. Cell Cycle, 2007, 6(16): 2010-8.
  • 8Tavazoie SF, Alarcon C, Oskarsson T, et al. Endogenous human microRNAs that suppress breast cancer metastasis [ J ]. Nature, 2008, 451(7175): 147-52.
  • 9Yu F, Yao H, Zhu P, et al. let-7 regulates self-renewal and tumorigenesis of breast cancer cells [J]. Cell, 2007, 131 (6): 1109-23.
  • 10Mishra PJ, Humeniuk R, Mishra PJ, et al. A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance [J]. Proe Natl Acad Sci USA, 2007, 104 (33): 13513-8.

共引文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部